

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by symbiont of host defense response (GO:0052509) | 6.97704450 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 6.97704450 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.97704450 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.97704450 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.97704450 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 6.97704450 |
| 7 | response to peptidoglycan (GO:0032494) | 6.01504610 |
| 8 | negative regulation of cell killing (GO:0031342) | 5.50682337 |
| 9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.50682337 |
| 10 | neutrophil activation involved in immune response (GO:0002283) | 5.46843985 |
| 11 | positive regulation of chemokine biosynthetic process (GO:0045080) | 5.21537285 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.90153860 |
| 13 | macrophage activation involved in immune response (GO:0002281) | 4.89766094 |
| 14 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.79520730 |
| 15 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.70924390 |
| 16 | response to host immune response (GO:0052572) | 4.70924390 |
| 17 | detection of other organism (GO:0098543) | 4.69967006 |
| 18 | positive regulation of heat generation (GO:0031652) | 4.64918719 |
| 19 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.62348254 |
| 20 | positive regulation of interferon-alpha production (GO:0032727) | 4.57340759 |
| 21 | cellular extravasation (GO:0045123) | 4.56657765 |
| 22 | detection of external biotic stimulus (GO:0098581) | 4.50499740 |
| 23 | respiratory burst (GO:0045730) | 4.42778309 |
| 24 | regulation of interferon-alpha production (GO:0032647) | 4.41672540 |
| 25 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.30405389 |
| 26 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.28587603 |
| 27 | regulation of fever generation (GO:0031620) | 4.28574060 |
| 28 | immunoglobulin mediated immune response (GO:0016064) | 4.28316444 |
| 29 | reactive oxygen species biosynthetic process (GO:1903409) | 4.26762342 |
| 30 | detection of bacterium (GO:0016045) | 4.24586018 |
| 31 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.24144086 |
| 32 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.22723915 |
| 33 | regulation of chemokine biosynthetic process (GO:0045073) | 4.20986481 |
| 34 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.20149216 |
| 35 | response to host (GO:0075136) | 4.20149216 |
| 36 | response to host defenses (GO:0052200) | 4.20149216 |
| 37 | response to muramyl dipeptide (GO:0032495) | 4.19940174 |
| 38 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.12431873 |
| 39 | superoxide anion generation (GO:0042554) | 4.08229339 |
| 40 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.02028597 |
| 41 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.01715567 |
| 42 | granulocyte activation (GO:0036230) | 4.00817907 |
| 43 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.99117475 |
| 44 | microglial cell activation (GO:0001774) | 3.97778587 |
| 45 | natural killer cell mediated immunity (GO:0002228) | 3.95931665 |
| 46 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.95931665 |
| 47 | regulation of gamma-delta T cell activation (GO:0046643) | 3.90028918 |
| 48 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.81316609 |
| 49 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.79557242 |
| 50 | neutrophil activation (GO:0042119) | 3.76739419 |
| 51 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.72334465 |
| 52 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.69655616 |
| 53 | negative regulation of interleukin-12 production (GO:0032695) | 3.69555747 |
| 54 | detection of molecule of bacterial origin (GO:0032490) | 3.65150297 |
| 55 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.63162631 |
| 56 | positive regulation of mast cell degranulation (GO:0043306) | 3.63162631 |
| 57 | neutrophil mediated immunity (GO:0002446) | 3.62881213 |
| 58 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.61497602 |
| 59 | myeloid cell activation involved in immune response (GO:0002275) | 3.58065036 |
| 60 | positive regulation of interferon-beta production (GO:0032728) | 3.54450756 |
| 61 | negative regulation of T cell mediated immunity (GO:0002710) | 3.53321561 |
| 62 | macrophage activation (GO:0042116) | 3.52384843 |
| 63 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.49242757 |
| 64 | I-kappaB phosphorylation (GO:0007252) | 3.47943407 |
| 65 | regulation of heat generation (GO:0031650) | 3.47204506 |
| 66 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.45541729 |
| 67 | leukocyte aggregation (GO:0070486) | 3.42856852 |
| 68 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.42258391 |
| 69 | regulation of chronic inflammatory response (GO:0002676) | 3.40396229 |
| 70 | regulation of mononuclear cell migration (GO:0071675) | 3.39870865 |
| 71 | myeloid leukocyte mediated immunity (GO:0002444) | 3.38807190 |
| 72 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.36492563 |
| 73 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.36421300 |
| 74 | type I interferon signaling pathway (GO:0060337) | 3.36094300 |
| 75 | cellular response to type I interferon (GO:0071357) | 3.36094300 |
| 76 | leukocyte mediated cytotoxicity (GO:0001909) | 3.36010322 |
| 77 | regulation of mast cell degranulation (GO:0043304) | 3.35131327 |
| 78 | response to type I interferon (GO:0034340) | 3.33166260 |
| 79 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.32599688 |
| 80 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.30718049 |
| 81 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.29169348 |
| 82 | cytokine secretion (GO:0050663) | 3.27178543 |
| 83 | regulation of tolerance induction (GO:0002643) | 3.27061145 |
| 84 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.26678492 |
| 85 | response to interleukin-15 (GO:0070672) | 3.25685945 |
| 86 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.25159111 |
| 87 | positive regulation of mast cell activation (GO:0033005) | 3.24894564 |
| 88 | negative regulation of interleukin-17 production (GO:0032700) | 3.24232505 |
| 89 | negative regulation of viral genome replication (GO:0045071) | 3.24125587 |
| 90 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.23446252 |
| 91 | regulation of podosome assembly (GO:0071801) | 3.23037213 |
| 92 | defense response to protozoan (GO:0042832) | 3.22224772 |
| 93 | T-helper 1 type immune response (GO:0042088) | 3.22164779 |
| 94 | regulation of T cell tolerance induction (GO:0002664) | 3.21366267 |
| 95 | response to protozoan (GO:0001562) | 3.19383039 |
| 96 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.18228206 |
| 97 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.16471053 |
| 98 | positive regulation of chemokine production (GO:0032722) | 3.15899475 |
| 99 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.15773657 |
| 100 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.15043190 |
| 101 | neutrophil chemotaxis (GO:0030593) | 3.14846682 |
| 102 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.14325821 |
| 103 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.13531955 |
| 104 | NIK/NF-kappaB signaling (GO:0038061) | 3.12635795 |
| 105 | B cell mediated immunity (GO:0019724) | 3.12458795 |
| 106 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.10049642 |
| 107 | positive regulation of antigen processing and presentation (GO:0002579) | 3.09683501 |
| 108 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.08941396 |
| 109 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.08300276 |
| 110 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.07583533 |
| 111 | neutrophil migration (GO:1990266) | 3.06683634 |
| 112 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.04499326 |
| 113 | cellular response to interleukin-15 (GO:0071350) | 3.04296141 |
| 114 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.04167940 |
| 115 | myeloid leukocyte activation (GO:0002274) | 3.03670646 |
| 116 | modulation by symbiont of host cellular process (GO:0044068) | 3.02473875 |
| 117 | germinal center formation (GO:0002467) | 3.01355908 |
| 118 | detection of biotic stimulus (GO:0009595) | 3.00288929 |
| 119 | positive regulation of type 2 immune response (GO:0002830) | 3.00261471 |
| 120 | positive regulation of interleukin-12 production (GO:0032735) | 2.97253236 |
| 121 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.96707724 |
| 122 | cellular response to virus (GO:0098586) | 2.96405554 |
| 123 | cellular response to lipopolysaccharide (GO:0071222) | 2.95725749 |
| 124 | cellular response to molecule of bacterial origin (GO:0071219) | 2.95606219 |
| 125 | low-density lipoprotein particle clearance (GO:0034383) | 2.94644611 |
| 126 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.94011358 |
| 127 | leukocyte degranulation (GO:0043299) | 2.93946865 |
| 128 | regulation of mast cell activation (GO:0033003) | 2.93684039 |
| 129 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.93219174 |
| 130 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.92784291 |
| 131 | dendritic cell chemotaxis (GO:0002407) | 2.92428471 |
| 132 | positive regulation of interleukin-6 production (GO:0032755) | 2.92233201 |
| 133 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.92231853 |
| 134 | negative regulation of lipid storage (GO:0010888) | 2.91696833 |
| 135 | regulation of leukocyte degranulation (GO:0043300) | 2.90570667 |
| 136 | dendritic cell migration (GO:0036336) | 2.90035526 |
| 137 | regulation of interleukin-12 production (GO:0032655) | 2.89198146 |
| 138 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.88953351 |
| 139 | negative regulation of interleukin-6 production (GO:0032715) | 2.86216704 |
| 140 | positive regulation of tolerance induction (GO:0002645) | 2.85395871 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.36824576 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.01334760 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.95378044 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.58868366 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.48640167 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.43281571 |
| 7 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 4.26889022 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.02051568 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.98335630 |
| 10 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.50915085 |
| 11 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.28376876 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.22458113 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.20369136 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.88867017 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.77486668 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.73820292 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.49876051 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.49736350 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.38897266 |
| 20 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.15070268 |
| 21 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.09423959 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.06248265 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.05019000 |
| 24 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.80430052 |
| 25 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.80390259 |
| 26 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.75911845 |
| 27 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.75674216 |
| 28 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.75472035 |
| 29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.75110044 |
| 30 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.72411988 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.70049299 |
| 32 | SPI1_23127762_ChIP-Seq_K562_Human | 1.69742957 |
| 33 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.67329269 |
| 34 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.64521268 |
| 35 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.53369490 |
| 36 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52036870 |
| 37 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.49957399 |
| 38 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.46894712 |
| 39 | MYB_26560356_Chip-Seq_TH2_Human | 1.46301907 |
| 40 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.41369815 |
| 41 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.40208061 |
| 42 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.39791114 |
| 43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.39310320 |
| 44 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.37184774 |
| 45 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.35598574 |
| 46 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.32985246 |
| 47 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32610713 |
| 48 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.30940827 |
| 49 | MAF_26560356_Chip-Seq_TH1_Human | 1.30241640 |
| 50 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.29407575 |
| 51 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.28706959 |
| 52 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22993810 |
| 53 | MYB_26560356_Chip-Seq_TH1_Human | 1.20630601 |
| 54 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.18092078 |
| 55 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17339457 |
| 56 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17277752 |
| 57 | * VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13861321 |
| 58 | GATA3_26560356_Chip-Seq_TH2_Human | 1.12939142 |
| 59 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08468869 |
| 60 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.06140130 |
| 61 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.06109193 |
| 62 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.05202869 |
| 63 | GATA1_22025678_ChIP-Seq_K562_Human | 1.04707064 |
| 64 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.03953722 |
| 65 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03553847 |
| 66 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.03383731 |
| 67 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.02293850 |
| 68 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00600856 |
| 69 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.99573460 |
| 70 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.98811777 |
| 71 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98342849 |
| 72 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.97090290 |
| 73 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.95225364 |
| 74 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.95225364 |
| 75 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94969822 |
| 76 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.93706025 |
| 77 | UTX_26944678_Chip-Seq_JUKART_Human | 0.91884749 |
| 78 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.84369668 |
| 79 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.83765962 |
| 80 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.83242508 |
| 81 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.83106708 |
| 82 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83078921 |
| 83 | MYC_22102868_ChIP-Seq_BL_Human | 0.81951440 |
| 84 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.81620931 |
| 85 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.81475062 |
| 86 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.80855083 |
| 87 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.79907922 |
| 88 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.79565447 |
| 89 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.79461299 |
| 90 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79257221 |
| 91 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78147795 |
| 92 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.77192768 |
| 93 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.76976317 |
| 94 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.75939069 |
| 95 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.75572362 |
| 96 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.75572362 |
| 97 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75158341 |
| 98 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.74613999 |
| 99 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.74383751 |
| 100 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73883885 |
| 101 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.73071375 |
| 102 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.72245326 |
| 103 | GATA2_19941826_ChIP-Seq_K562_Human | 0.71532424 |
| 104 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.71184109 |
| 105 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.69215623 |
| 106 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.68383156 |
| 107 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.68230345 |
| 108 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.66082597 |
| 109 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.63845407 |
| 110 | MAF_26560356_Chip-Seq_TH2_Human | 0.63793490 |
| 111 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.63768158 |
| 112 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.62094055 |
| 113 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.62061947 |
| 114 | GATA3_26560356_Chip-Seq_TH1_Human | 0.61930105 |
| 115 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.61386670 |
| 116 | CJUN_26792858_Chip-Seq_BT549_Human | 0.61301296 |
| 117 | GATA1_19941826_ChIP-Seq_K562_Human | 0.60585712 |
| 118 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.59762033 |
| 119 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.57366332 |
| 120 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.57256013 |
| 121 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.56791626 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009785_altered_susceptibility_to | 4.09196289 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.06583794 |
| 3 | MP0003436_decreased_susceptibility_to | 4.03678060 |
| 4 | MP0003303_peritoneal_inflammation | 3.78823829 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.38184218 |
| 6 | * MP0002419_abnormal_innate_immunity | 3.35578380 |
| 7 | MP0003724_increased_susceptibility_to | 3.32512353 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.25159048 |
| 9 | MP0006082_CNS_inflammation | 3.07072979 |
| 10 | * MP0005025_abnormal_response_to | 3.00934921 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.78007344 |
| 12 | MP0001790_abnormal_immune_system | 2.69026077 |
| 13 | MP0005387_immune_system_phenotype | 2.69026077 |
| 14 | MP0004510_myositis | 2.66545060 |
| 15 | MP0009278_abnormal_bone_marrow | 2.58730357 |
| 16 | * MP0002452_abnormal_antigen_presenting | 2.58002332 |
| 17 | MP0000685_abnormal_immune_system | 2.51141745 |
| 18 | MP0000569_abnormal_digit_pigmentation | 2.49368033 |
| 19 | * MP0002723_abnormal_immune_serum | 2.44684479 |
| 20 | MP0001800_abnormal_humoral_immune | 2.42718126 |
| 21 | MP0004947_skin_inflammation | 2.38473787 |
| 22 | MP0005464_abnormal_platelet_physiology | 2.27290237 |
| 23 | MP0001533_abnormal_skeleton_physiology | 2.24471123 |
| 24 | MP0005671_abnormal_response_to | 2.24028383 |
| 25 | MP0003172_abnormal_lysosome_physiology | 2.19255835 |
| 26 | * MP0001819_abnormal_immune_cell | 2.12703383 |
| 27 | * MP0002420_abnormal_adaptive_immunity | 2.09040921 |
| 28 | MP0009764_decreased_sensitivity_to | 2.08612488 |
| 29 | MP0003448_altered_tumor_morphology | 2.00518872 |
| 30 | MP0001845_abnormal_inflammatory_respons | 1.93533264 |
| 31 | MP0003075_altered_response_to | 1.89465195 |
| 32 | MP0005167_abnormal_blood-brain_barrier | 1.89096179 |
| 33 | MP0000343_altered_response_to | 1.87103284 |
| 34 | MP0002405_respiratory_system_inflammati | 1.77609258 |
| 35 | MP0008469_abnormal_protein_level | 1.75991676 |
| 36 | MP0001853_heart_inflammation | 1.69635388 |
| 37 | MP0002006_tumorigenesis | 1.67735761 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.64548541 |
| 39 | MP0000604_amyloidosis | 1.64068836 |
| 40 | MP0001545_abnormal_hematopoietic_system | 1.61598351 |
| 41 | MP0005397_hematopoietic_system_phenotyp | 1.61598351 |
| 42 | MP0002998_abnormal_bone_remodeling | 1.52683416 |
| 43 | MP0000858_altered_metastatic_potential | 1.46096578 |
| 44 | * MP0000716_abnormal_immune_system | 1.41598206 |
| 45 | MP0005451_abnormal_body_composition | 1.39649342 |
| 46 | MP0004858_abnormal_nervous_system | 1.38873399 |
| 47 | MP0002132_abnormal_respiratory_system | 1.37841062 |
| 48 | MP0008260_abnormal_autophagy | 1.36408723 |
| 49 | MP0000465_gastrointestinal_hemorrhage | 1.36168525 |
| 50 | MP0003195_calcinosis | 1.33900744 |
| 51 | MP0005164_abnormal_response_to | 1.33560096 |
| 52 | MP0002398_abnormal_bone_marrow | 1.32410589 |
| 53 | MP0009333_abnormal_splenocyte_physiolog | 1.31285683 |
| 54 | MP0005166_decreased_susceptibility_to | 1.30277615 |
| 55 | MP0003183_abnormal_peptide_metabolism | 1.27987712 |
| 56 | MP0003300_gastrointestinal_ulcer | 1.26195963 |
| 57 | MP0005310_abnormal_salivary_gland | 1.22248524 |
| 58 | MP0008004_abnormal_stomach_pH | 1.21556380 |
| 59 | MP0005076_abnormal_cell_differentiation | 1.20036565 |
| 60 | MP0003806_abnormal_nucleotide_metabolis | 1.18448614 |
| 61 | MP0005174_abnormal_tail_pigmentation | 1.17549345 |
| 62 | MP0003186_abnormal_redox_activity | 1.17331132 |
| 63 | MP0003828_pulmonary_edema | 1.16665795 |
| 64 | MP0000689_abnormal_spleen_morphology | 1.12455645 |
| 65 | * MP0002429_abnormal_blood_cell | 1.10727133 |
| 66 | MP0009840_abnormal_foam_cell | 1.10212296 |
| 67 | MP0006054_spinal_hemorrhage | 1.09374092 |
| 68 | MP0009763_increased_sensitivity_to | 1.08648546 |
| 69 | MP0010307_abnormal_tumor_latency | 1.08299318 |
| 70 | MP0002332_abnormal_exercise_endurance | 1.08215887 |
| 71 | MP0003866_abnormal_defecation | 1.07419580 |
| 72 | MP0002277_abnormal_respiratory_mucosa | 1.05362518 |
| 73 | MP0005390_skeleton_phenotype | 1.03356379 |
| 74 | MP0000371_diluted_coat_color | 1.02679340 |
| 75 | MP0003646_muscle_fatigue | 1.01539554 |
| 76 | MP0003191_abnormal_cellular_cholesterol | 1.00767313 |
| 77 | MP0003453_abnormal_keratinocyte_physiol | 1.00379237 |
| 78 | MP0004381_abnormal_hair_follicle | 1.00037150 |
| 79 | MP0002722_abnormal_immune_system | 0.99311569 |
| 80 | MP0002254_reproductive_system_inflammat | 0.96731064 |
| 81 | MP0004782_abnormal_surfactant_physiolog | 0.92716648 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 0.91349796 |
| 83 | MP0001851_eye_inflammation | 0.90626104 |
| 84 | MP0000703_abnormal_thymus_morphology | 0.88949905 |
| 85 | MP0003690_abnormal_glial_cell | 0.88785836 |
| 86 | MP0002933_joint_inflammation | 0.87317729 |
| 87 | MP0000015_abnormal_ear_pigmentation | 0.86907821 |
| 88 | MP0003045_fibrosis | 0.86626071 |
| 89 | MP0002138_abnormal_hepatobiliary_system | 0.85911296 |
| 90 | MP0002166_altered_tumor_susceptibility | 0.85744714 |
| 91 | MP0001663_abnormal_digestive_system | 0.85513450 |
| 92 | MP0003566_abnormal_cell_adhesion | 0.83845895 |
| 93 | MP0000249_abnormal_blood_vessel | 0.82543108 |
| 94 | MP0003091_abnormal_cell_migration | 0.81579586 |
| 95 | MP0010352_gastrointestinal_tract_polyps | 0.76246937 |
| 96 | MP0005083_abnormal_biliary_tract | 0.75919443 |
| 97 | MP0003221_abnormal_cardiomyocyte_apopto | 0.74366354 |
| 98 | MP0008874_decreased_physiological_sensi | 0.71338829 |
| 99 | MP0001501_abnormal_sleep_pattern | 0.69287848 |
| 100 | MP0000920_abnormal_myelination | 0.64421520 |
| 101 | MP0005257_abnormal_intraocular_pressure | 0.64014590 |
| 102 | MP0005023_abnormal_wound_healing | 0.63564815 |
| 103 | MP0003795_abnormal_bone_structure | 0.63175119 |
| 104 | MP0002396_abnormal_hematopoietic_system | 0.63109979 |
| 105 | MP0004883_abnormal_blood_vessel | 0.59991976 |
| 106 | MP0002136_abnormal_kidney_physiology | 0.57910272 |
| 107 | MP0002693_abnormal_pancreas_physiology | 0.55761962 |
| 108 | MP0008873_increased_physiological_sensi | 0.54760128 |
| 109 | MP0004808_abnormal_hematopoietic_stem | 0.54708409 |
| 110 | MP0005376_homeostasis/metabolism_phenot | 0.54644756 |
| 111 | MP0000767_abnormal_smooth_muscle | 0.52959664 |
| 112 | MP0001958_emphysema | 0.51429281 |
| 113 | MP0001873_stomach_inflammation | 0.51032620 |
| 114 | MP0005319_abnormal_enzyme/_coenzyme | 0.49426591 |
| 115 | MP0009765_abnormal_xenobiotic_induced | 0.48289159 |
| 116 | MP0005075_abnormal_melanosome_morpholog | 0.48017018 |
| 117 | MP0004130_abnormal_muscle_cell | 0.47595531 |
| 118 | MP0005197_abnormal_uvea_morphology | 0.46927292 |
| 119 | MP0001191_abnormal_skin_condition | 0.45983894 |
| 120 | MP0005535_abnormal_body_temperature | 0.43825380 |
| 121 | MP0003763_abnormal_thymus_physiology | 0.43807962 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 8.20648602 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 7.53090650 |
| 3 | Eczematoid dermatitis (HP:0000976) | 7.40612607 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.71395449 |
| 5 | Stomatitis (HP:0010280) | 6.44676785 |
| 6 | Mediastinal lymphadenopathy (HP:0100721) | 5.79103644 |
| 7 | Abnormality of macrophages (HP:0004311) | 5.66538417 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.50681741 |
| 9 | Gingivitis (HP:0000230) | 4.72620996 |
| 10 | Autoimmune thrombocytopenia (HP:0001973) | 4.53709583 |
| 11 | Retrobulbar optic neuritis (HP:0100654) | 4.48253551 |
| 12 | Optic neuritis (HP:0100653) | 4.48253551 |
| 13 | Orchitis (HP:0100796) | 4.43901968 |
| 14 | Recurrent skin infections (HP:0001581) | 4.35380062 |
| 15 | Myositis (HP:0100614) | 4.19615137 |
| 16 | Prostate neoplasm (HP:0100787) | 4.03298265 |
| 17 | Obstructive lung disease (HP:0006536) | 4.02429660 |
| 18 | Chronic obstructive pulmonary disease (HP:0006510) | 4.02429660 |
| 19 | Increased cerebral lipofuscin (HP:0011813) | 3.99874778 |
| 20 | Vacuolated lymphocytes (HP:0001922) | 3.91075846 |
| 21 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.83645762 |
| 22 | Vasculitis (HP:0002633) | 3.73757884 |
| 23 | Recurrent fungal infections (HP:0002841) | 3.68270345 |
| 24 | Thick nail (HP:0001805) | 3.63663049 |
| 25 | Encephalitis (HP:0002383) | 3.61353593 |
| 26 | Spontaneous hematomas (HP:0007420) | 3.49432216 |
| 27 | Urticaria (HP:0001025) | 3.37863606 |
| 28 | Periodontitis (HP:0000704) | 3.33847420 |
| 29 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.33068093 |
| 30 | Increased IgM level (HP:0003496) | 3.30406607 |
| 31 | Tetraparesis (HP:0002273) | 3.29820090 |
| 32 | Recurrent viral infections (HP:0004429) | 3.28534366 |
| 33 | Systemic lupus erythematosus (HP:0002725) | 3.25058664 |
| 34 | Pustule (HP:0200039) | 3.23243997 |
| 35 | T lymphocytopenia (HP:0005403) | 3.13030199 |
| 36 | Interstitial pulmonary disease (HP:0006530) | 3.11076615 |
| 37 | Abnormality of T cell number (HP:0011839) | 3.09255210 |
| 38 | Hypochromic microcytic anemia (HP:0004840) | 3.03464385 |
| 39 | Axonal loss (HP:0003447) | 3.00373736 |
| 40 | Pulmonary infiltrates (HP:0002113) | 3.00353053 |
| 41 | Leukocytosis (HP:0001974) | 2.94601242 |
| 42 | Basal ganglia calcification (HP:0002135) | 2.94468833 |
| 43 | Cellulitis (HP:0100658) | 2.92837111 |
| 44 | Chest pain (HP:0100749) | 2.91235713 |
| 45 | Increased IgE level (HP:0003212) | 2.88409783 |
| 46 | Gangrene (HP:0100758) | 2.83858684 |
| 47 | Hematochezia (HP:0002573) | 2.81221247 |
| 48 | Pulmonary embolism (HP:0002204) | 2.75115941 |
| 49 | Premature loss of primary teeth (HP:0006323) | 2.74496075 |
| 50 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.69842620 |
| 51 | Amyloidosis (HP:0011034) | 2.68729097 |
| 52 | Hypochromic anemia (HP:0001931) | 2.66893768 |
| 53 | Prolonged bleeding time (HP:0003010) | 2.65480487 |
| 54 | Osteomyelitis (HP:0002754) | 2.65027622 |
| 55 | Disinhibition (HP:0000734) | 2.62873518 |
| 56 | Abnormality of glycolipid metabolism (HP:0010969) | 2.61301397 |
| 57 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.61301397 |
| 58 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.61301397 |
| 59 | Loss of speech (HP:0002371) | 2.59195966 |
| 60 | Meningitis (HP:0001287) | 2.57252092 |
| 61 | Recurrent pneumonia (HP:0006532) | 2.56330314 |
| 62 | Recurrent cutaneous fungal infections (HP:0011370) | 2.51776346 |
| 63 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.51776346 |
| 64 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.51669189 |
| 65 | Keratoconjunctivitis sicca (HP:0001097) | 2.51584001 |
| 66 | Esophageal neoplasm (HP:0100751) | 2.48907137 |
| 67 | Neoplasm of head and neck (HP:0012288) | 2.48907137 |
| 68 | Arterial thrombosis (HP:0004420) | 2.43720018 |
| 69 | Glomerulonephritis (HP:0000099) | 2.42796126 |
| 70 | Gingival bleeding (HP:0000225) | 2.40438152 |
| 71 | Epistaxis (HP:0000421) | 2.39005117 |
| 72 | Dysostosis multiplex (HP:0000943) | 2.38517862 |
| 73 | Chronic otitis media (HP:0000389) | 2.38032308 |
| 74 | Abnormality of T cells (HP:0002843) | 2.35017666 |
| 75 | Abnormality of the endocardium (HP:0004306) | 2.30778633 |
| 76 | Myocardial infarction (HP:0001658) | 2.30463233 |
| 77 | Nausea (HP:0002018) | 2.30387907 |
| 78 | Keratitis (HP:0000491) | 2.28631256 |
| 79 | Keratoconjunctivitis (HP:0001096) | 2.27274387 |
| 80 | Vertigo (HP:0002321) | 2.24158734 |
| 81 | Bone pain (HP:0002653) | 2.23692028 |
| 82 | Hemoptysis (HP:0002105) | 2.22483967 |
| 83 | Vertebral compression fractures (HP:0002953) | 2.21892983 |
| 84 | Inflammation of the large intestine (HP:0002037) | 2.21375248 |
| 85 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.20791315 |
| 86 | Granulocytopenia (HP:0001913) | 2.19932293 |
| 87 | Abnormality of the prostate (HP:0008775) | 2.19519101 |
| 88 | Recurrent lower respiratory tract infections (HP:0002783) | 2.19259288 |
| 89 | Hypergammaglobulinemia (HP:0010702) | 2.19218418 |
| 90 | Abnormality of iron homeostasis (HP:0011031) | 2.18031017 |
| 91 | Polyneuropathy (HP:0001271) | 2.17162069 |
| 92 | Acne (HP:0001061) | 2.15133065 |
| 93 | Microcytic anemia (HP:0001935) | 2.12577651 |
| 94 | Gastrointestinal infarctions (HP:0005244) | 2.10537579 |
| 95 | Glomerulopathy (HP:0100820) | 2.10407444 |
| 96 | Abnormality of the peritoneum (HP:0002585) | 2.07120449 |
| 97 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.06815907 |
| 98 | Osteolytic defects of the hand bones (HP:0009699) | 2.06815907 |
| 99 | Gastrointestinal inflammation (HP:0004386) | 2.04434925 |
| 100 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.01345779 |
| 101 | Mucopolysacchariduria (HP:0008155) | 2.01345779 |
| 102 | Hepatosplenomegaly (HP:0001433) | 2.01007723 |
| 103 | Increased serum ferritin (HP:0003281) | 1.98718503 |
| 104 | Purpura (HP:0000979) | 1.98273638 |
| 105 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.97175038 |
| 106 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.97175038 |
| 107 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.97175038 |
| 108 | Pathologic fracture (HP:0002756) | 1.95900599 |
| 109 | Anorexia (HP:0002039) | 1.95765284 |
| 110 | Eosinophilia (HP:0001880) | 1.94168662 |
| 111 | Restrictive lung disease (HP:0002091) | 1.93574889 |
| 112 | Arthralgia (HP:0002829) | 1.93305145 |
| 113 | Poor head control (HP:0002421) | 1.92980918 |
| 114 | Nephritis (HP:0000123) | 1.92358721 |
| 115 | Abnormality of the pericardium (HP:0001697) | 1.91912615 |
| 116 | Sepsis (HP:0100806) | 1.90446758 |
| 117 | Lymphopenia (HP:0001888) | 1.90255155 |
| 118 | Porencephaly (HP:0002132) | 1.90020309 |
| 119 | Joint swelling (HP:0001386) | 1.88414631 |
| 120 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85851545 |
| 121 | Cheilitis (HP:0100825) | 1.85363352 |
| 122 | Joint hemorrhage (HP:0005261) | 1.85257263 |
| 123 | Petechiae (HP:0000967) | 1.83651368 |
| 124 | Mutism (HP:0002300) | 1.83580769 |
| 125 | Abnormality of T cell physiology (HP:0011840) | 1.81412694 |
| 126 | Acute hepatic failure (HP:0006554) | 1.81371268 |
| 127 | Abnormality of eosinophils (HP:0001879) | 1.81211077 |
| 128 | Peritonitis (HP:0002586) | 1.80960161 |
| 129 | Agnosia (HP:0010524) | 1.80828457 |
| 130 | Progressive visual loss (HP:0000529) | 1.80642726 |
| 131 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.80453838 |
| 132 | Abnormality of the pleura (HP:0002103) | 1.79821201 |
| 133 | Skin ulcer (HP:0200042) | 1.77151742 |
| 134 | Autoimmune hemolytic anemia (HP:0001890) | 1.77033619 |
| 135 | Albinism (HP:0001022) | 1.76085471 |
| 136 | Gastrointestinal stroma tumor (HP:0100723) | 1.76066489 |
| 137 | Episodic fever (HP:0001954) | 1.75487553 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.47440195 |
| 2 | MAP3K14 | 5.02061214 |
| 3 | IRAK3 | 4.04985797 |
| 4 | TBK1 | 4.00236283 |
| 5 | PBK | 3.69818643 |
| 6 | BLK | 3.61060049 |
| 7 | IRAK4 | 3.32679759 |
| 8 | IKBKE | 3.15529549 |
| 9 | TYK2 | 2.95621642 |
| 10 | IKBKB | 2.52200117 |
| 11 | MAP3K13 | 2.29671007 |
| 12 | JAK3 | 2.29667394 |
| 13 | TXK | 2.24409411 |
| 14 | KIT | 2.10003974 |
| 15 | TAOK1 | 2.00847808 |
| 16 | MAP4K1 | 1.97873031 |
| 17 | TNK2 | 1.97592965 |
| 18 | JAK1 | 1.89980632 |
| 19 | GRK6 | 1.77525342 |
| 20 | FGR | 1.71066254 |
| 21 | ERN1 | 1.70783559 |
| 22 | CSK | 1.62168067 |
| 23 | CHUK | 1.61027107 |
| 24 | RPS6KA4 | 1.34606496 |
| 25 | MATK | 1.28820871 |
| 26 | PRPF4B | 1.23793344 |
| 27 | HCK | 1.22247980 |
| 28 | BMX | 1.22227006 |
| 29 | MARK3 | 1.21544070 |
| 30 | SYK | 1.19192306 |
| 31 | LYN | 1.18262425 |
| 32 | TAOK3 | 1.17129694 |
| 33 | ZAP70 | 1.16943832 |
| 34 | PIM2 | 1.11483812 |
| 35 | ACVR1B | 1.10321801 |
| 36 | FRK | 1.10000977 |
| 37 | LCK | 1.09185767 |
| 38 | FES | 1.02315699 |
| 39 | JAK2 | 1.02290956 |
| 40 | ABL2 | 1.01301276 |
| 41 | BMPR2 | 1.00864732 |
| 42 | PIM1 | 0.99008201 |
| 43 | CSF1R | 0.98591335 |
| 44 | MST1R | 0.96358407 |
| 45 | EIF2AK2 | 0.93920453 |
| 46 | YES1 | 0.93524231 |
| 47 | NME2 | 0.90609143 |
| 48 | EPHB1 | 0.87518591 |
| 49 | STK4 | 0.85382248 |
| 50 | ERBB4 | 0.82969008 |
| 51 | MAP3K5 | 0.82680779 |
| 52 | PTK2B | 0.81559073 |
| 53 | MAP3K6 | 0.81399617 |
| 54 | SIK2 | 0.80872735 |
| 55 | EGFR | 0.77752883 |
| 56 | BTK | 0.77029053 |
| 57 | DAPK2 | 0.75623380 |
| 58 | MST4 | 0.75398344 |
| 59 | MARK2 | 0.75269871 |
| 60 | PRKCD | 0.73829529 |
| 61 | MAP3K2 | 0.71737889 |
| 62 | SIK3 | 0.71110501 |
| 63 | NEK9 | 0.70965875 |
| 64 | MAP2K4 | 0.69753797 |
| 65 | ABL1 | 0.65964437 |
| 66 | CDC42BPA | 0.65234450 |
| 67 | RIPK1 | 0.64986230 |
| 68 | ADRBK2 | 0.64383094 |
| 69 | PIK3CG | 0.62950618 |
| 70 | MAP2K6 | 0.60892605 |
| 71 | KSR1 | 0.60399161 |
| 72 | TEC | 0.60001698 |
| 73 | STK10 | 0.59866765 |
| 74 | CAMKK2 | 0.59647846 |
| 75 | IRAK2 | 0.58368226 |
| 76 | DYRK3 | 0.57137540 |
| 77 | MAP3K11 | 0.56617102 |
| 78 | CDK19 | 0.55616784 |
| 79 | FGFR3 | 0.55575982 |
| 80 | TTN | 0.53999723 |
| 81 | PLK2 | 0.52924756 |
| 82 | DAPK3 | 0.52393411 |
| 83 | SGK3 | 0.50536291 |
| 84 | PRKD2 | 0.50063282 |
| 85 | MAP3K10 | 0.49346360 |
| 86 | MAP3K1 | 0.48503682 |
| 87 | STK11 | 0.48467108 |
| 88 | KSR2 | 0.48382785 |
| 89 | SGK2 | 0.47498954 |
| 90 | CDK12 | 0.45671841 |
| 91 | MAP2K3 | 0.45205390 |
| 92 | PTK6 | 0.44764029 |
| 93 | MAPK7 | 0.43345157 |
| 94 | RAF1 | 0.42491742 |
| 95 | HIPK2 | 0.41911700 |
| 96 | STK3 | 0.41795985 |
| 97 | IRAK1 | 0.40930118 |
| 98 | FYN | 0.40839591 |
| 99 | PDPK1 | 0.40654570 |
| 100 | FGFR4 | 0.39525496 |
| 101 | NLK | 0.38483090 |
| 102 | STK38 | 0.38460041 |
| 103 | MAP3K3 | 0.37082879 |
| 104 | TGFBR2 | 0.37056540 |
| 105 | MAPK12 | 0.37038352 |
| 106 | GRK7 | 0.35511484 |
| 107 | PRKCZ | 0.35402712 |
| 108 | LRRK2 | 0.34986189 |
| 109 | CLK1 | 0.34824198 |
| 110 | TRPM7 | 0.34363877 |
| 111 | PDK1 | 0.34021249 |
| 112 | PDGFRB | 0.33702473 |
| 113 | PRKG2 | 0.33591133 |
| 114 | MOS | 0.32937314 |
| 115 | DYRK1B | 0.31055246 |
| 116 | RPS6KL1 | 0.31008320 |
| 117 | RPS6KC1 | 0.31008320 |
| 118 | MAP3K7 | 0.29754236 |
| 119 | MAPKAPK2 | 0.29000144 |
| 120 | ERBB3 | 0.28433116 |
| 121 | RPS6KA6 | 0.28090032 |
| 122 | PRKCQ | 0.27369008 |
| 123 | PRKAA2 | 0.25333016 |
| 124 | TAOK2 | 0.25121913 |
| 125 | ALK | 0.22713566 |
| 126 | CAMK1D | 0.21149738 |
| 127 | PKN1 | 0.20843771 |
| 128 | INSR | 0.20412172 |
| 129 | CDK6 | 0.20052633 |
| 130 | RPS6KA2 | 0.19546046 |
| 131 | EPHA3 | 0.19346823 |
| 132 | ARAF | 0.18965815 |
| 133 | BMPR1B | 0.18886272 |
| 134 | SGK1 | 0.17623710 |
| 135 | ITK | 0.17238478 |
| 136 | SRC | 0.15854353 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.61909109 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.40266018 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.10866273 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 3.03056768 |
| 5 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.98602817 |
| 6 | Legionellosis_Homo sapiens_hsa05134 | 2.95282324 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.78698683 |
| 8 | Malaria_Homo sapiens_hsa05144 | 2.56577751 |
| 9 | Pertussis_Homo sapiens_hsa05133 | 2.54929542 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 2.50519242 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.47881937 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.41954931 |
| 13 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.38670577 |
| 14 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.29723459 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.25780672 |
| 16 | * Tuberculosis_Homo sapiens_hsa05152 | 2.20624458 |
| 17 | Asthma_Homo sapiens_hsa05310 | 2.19802015 |
| 18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.19671900 |
| 19 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.02128656 |
| 20 | Measles_Homo sapiens_hsa05162 | 2.02110048 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.00265114 |
| 22 | Influenza A_Homo sapiens_hsa05164 | 1.92406442 |
| 23 | Salmonella infection_Homo sapiens_hsa05132 | 1.83414948 |
| 24 | Phagosome_Homo sapiens_hsa04145 | 1.76404171 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.60925232 |
| 26 | Lysosome_Homo sapiens_hsa04142 | 1.58231050 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.53652334 |
| 28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.53154416 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.47662449 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.47222591 |
| 31 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.33471617 |
| 32 | Apoptosis_Homo sapiens_hsa04210 | 1.32516984 |
| 33 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.27094622 |
| 34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.26100272 |
| 35 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.25916215 |
| 36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.25751657 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.24785843 |
| 38 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.10260191 |
| 39 | Hepatitis C_Homo sapiens_hsa05160 | 1.10127549 |
| 40 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.07399397 |
| 41 | Amoebiasis_Homo sapiens_hsa05146 | 1.05980402 |
| 42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.05693884 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.04343931 |
| 44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.02171494 |
| 45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.98221161 |
| 46 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.94809952 |
| 47 | Other glycan degradation_Homo sapiens_hsa00511 | 0.90297193 |
| 48 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.88295487 |
| 49 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.88221055 |
| 50 | Viral myocarditis_Homo sapiens_hsa05416 | 0.79303077 |
| 51 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.79096532 |
| 52 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.77610175 |
| 53 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.75757657 |
| 54 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.75130771 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.74332492 |
| 56 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.73897279 |
| 57 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.70052714 |
| 58 | Prion diseases_Homo sapiens_hsa05020 | 0.69029261 |
| 59 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.68982453 |
| 60 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.61899839 |
| 61 | Mineral absorption_Homo sapiens_hsa04978 | 0.60033106 |
| 62 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.59278689 |
| 63 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.56419218 |
| 64 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.55780068 |
| 65 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.54947895 |
| 66 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54006682 |
| 67 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53653163 |
| 68 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.51739945 |
| 69 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51564193 |
| 70 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.50707047 |
| 71 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.49876742 |
| 72 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49111998 |
| 73 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.48874801 |
| 74 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.47761749 |
| 75 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.45948823 |
| 76 | Platelet activation_Homo sapiens_hsa04611 | 0.45738062 |
| 77 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.45590263 |
| 78 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.44924524 |
| 79 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.44924000 |
| 80 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.41369183 |
| 81 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.40084896 |
| 82 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.38184536 |
| 83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38041647 |
| 84 | Insulin resistance_Homo sapiens_hsa04931 | 0.34675657 |
| 85 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.32994802 |
| 86 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.32642387 |
| 87 | Bladder cancer_Homo sapiens_hsa05219 | 0.32176364 |
| 88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.28971820 |
| 89 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.28801173 |
| 90 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.28457153 |
| 91 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.26426688 |
| 92 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.26250584 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.26137225 |
| 94 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.25825450 |
| 95 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.25240569 |
| 96 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.24524457 |
| 97 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.24314600 |
| 98 | Endometrial cancer_Homo sapiens_hsa05213 | 0.23737135 |
| 99 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.23263497 |
| 100 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.21587934 |
| 101 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.21441735 |
| 102 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.15675836 |
| 103 | HTLV-I infection_Homo sapiens_hsa05166 | 0.15292553 |
| 104 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.14092092 |
| 105 | Endocytosis_Homo sapiens_hsa04144 | 0.13311553 |
| 106 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.12807634 |
| 107 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.12783214 |
| 108 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.08750895 |
| 109 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.07551450 |
| 110 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.05084101 |

